Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnAISquareMore
CATL says mining, not refining, is battery making’s big hurdle

CATL says mining, not refining, is battery making’s big hurdle

Mining.comMining.com2026/07/02 03:49
By:Mining.com

Securing supplies of key raw materials has become a priority for the world’s largest manufacturer of electric vehicle batteries.

var rnd = window.rnd || Math.floor(Math.random() * 10e6); var pid472436 = window.pid472436 || rnd; var plc472436 = window.plc472436 || 0; var abkw = window.abkw || ''; var absrc = 'https://servedbyadbutler.com/adserve/;ID=181210;size=0x0;setID=472436;type=js;sw=' + screen.width + ';sh=' + screen.height + ';spr=' + window.devicePixelRatio + ';kw=' + abkw + ';pid=' + pid472436+ ';place=' + (plc472436++) + ';rnd=' + rnd + ';click=CLICK_MACRO_PLACEHOLDER'; document.write('
');

“Processing is not the bottleneck, but mining is,” Jiang Li, vice president of Contemporary Amperex Technology Co. Ltd., said in a recent interview. “We want to build our cost advantage with our upstream capabilities.”

China has a stranglehold on refining battery minerals, and customers such as Ford Motor Co. have warned in the past that processing is a bigger constraint on the industry than mining. 

But surging prices and uncertainties over supply are now pushing some battery makers to focus investments on extracting minerals. For all of its manufacturing heft, China still relies on imports of ores. To counter that, CATL plans to establish a new mining unit and has tapped Chen Jinghe, the founder of China’s biggest metals miner, as an adviser.

“Technology innovation can help us conquer shortages of metals in the medium to long term. But sometimes we don’t have enough time,” Li said. “The market can change rapidly. We have to face that difficulty, so mining is very important.”

CATL’s current roster of mining investments includes domestic and overseas projects covering lithium, phosphate and cobalt. Its big lithium mine in China’s Jiangxi province, however, has seen disruptions since August. 

That’s contributed to lithium’s wild swings in price. CATL is making advances in batteries that instead use sodium — a globally abundant element — which the company has dubbed an alternative risk management strategy.

“If the price of lithium goes up, then we can make more sodium-ion batteries,” said Li. 

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

The "Outlier" Investment Art in the New Era of Berky

他山之石观投资2026/09/14 09:22
The "Outlier" Investment Art in the New Era of Berky

Chevron (CVX.US) explores alternative hedging for Middle East supply disruptions: targets Argentina and the Mediterranean to drive global LNG growth, seeks deal with India

Chevron is focusing on Argentina and the Mediterranean region, seeking global growth in liquefied natural gas, and plans to reach an agreement with India.

智通财经2026/09/14 09:12
Chevron (CVX.US) explores alternative hedging for Middle East supply disruptions: targets Argentina and the Mediterranean to drive global LNG growth, seeks deal with India

Energy and food price pressures intensify, potentially triggering an inflation rebound! The Bank of England may struggle to remain "calm" as market rate hike bets surge

The upward pressure on energy prices caused by the unresolved Middle East war is mounting. New risks are also approaching, which may keep inflation above the Bank of England’s 2% target for most of next year.

智通财经2026/09/14 08:57
Energy and food price pressures intensify, potentially triggering an inflation rebound! The Bank of England may struggle to remain "calm" as market rate hike bets surge

AstraZeneca (AZN.US) Breast Cancer Drug Etcamah Faces Setback in Phase III Clinical Trial, Potentially Impacting Billions in Sales

Bloomberg Intelligence analyst John Murphy stated that the setback in AstraZeneca's breast cancer drug trial could reduce sales in 2035 by $2.6 billion to $3.8 billion.

智通财经2026/09/14 08:41
AstraZeneca (AZN.US) Breast Cancer Drug Etcamah Faces Setback in Phase III Clinical Trial, Potentially Impacting Billions in Sales